Closing the serological gap in the antiphospholipid syndrome: The value of "non-criteria" antiphospholipid antibodies

Journal of Rheumatology

Volumn 44, Issue 11, 2017, Pages 1597-1602

  Zohoury, Navid ^a   Bertolaccini, Maria Laura ^b   Rodriguez Garcia, Jose Luis ^b   Shums, Zakera ^a   Ateka Barrutia, Oier ^b   Sorice, Maurizio ^d   Norman, Gary L ^c   Khamashta, Munther ^b  

^a INOVA DIAGNOSTICS INC   (United States)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiphosphatidylserine prothrombin antibodies; Antiphospholipid antibodies autoimmune diseases; Antiphospholipid syndrome; Biomarkers

Indexed keywords

PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; BLOOD; IMMUNOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIOMARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 85032623643     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.170044     Document Type: Article

References (35)

1. Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. BMJ 1983;287:1088-9.
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
3. Adams M. Measurement of lupus anticoagulants: an update on quality in laboratory testing. Semin Thromb Hemost 2013; 39:267-71.
4. Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000;43:440-3.
5. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003;101:1333-4.
6. Hughes GR, Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis 2003;62:1127.
7. Rodriguez-Garcia JL, Bertolaccini ML, Cuadrado MJ, Sanna G, Ateku-Barrutia O, Khmashta MA. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called "seronegative APS"). Ann Rheum Dis 2012;71:242-4.
8. Lazurova I, Macejova Z, Tomkova Z, Remenar F, Boor A, Lazur J, et al. Severe limb necrosis: primary thrombotic microangiopathy or "seronegative" catastrophic antiphospholipid syndrome? A diagnostic dilemma. Clin Rheumatol 2007;26:1737-40.
9. Sanmarco M. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called "seronegative antiphospholipid syndrome". Autoimmun Rev 2009;9:90-2.
10. Cervera R, Conti F, Doria A, Iaccarino L, Valesini G. Does seronegative antiphospholipid syndrome really exist? Autoimmun Rev 2012;11:581-4.
11. Greaves M. Antiphospholipid syndrome: unusual clinical presentations. Thromb Res 2011;127 Suppl:S47-50.
12. Roggenbuck D, Egerer K, von Landenberg P, Hiermann R, Feist E, Burmester G, et al. Antiphospholipid antibody profiling: time for a new technical approach? Autoimmun Rev 2012;11:821-6.
13. Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, et al. Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis 2005;64:1639-43.
14. Alessandri C, Conti F, Pendolino M, Mancini R, Valesini G. New autoantigens in the antiphospholipid syndrome. Autoimmun Rev 2011;10:609-16.
15. Bertolaccini ML, Amengual O, Atsumi T, Binder WL, deLaat B, Forestiero R, et al. "Non-criteria" aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 2011;20:191-205.
16. Pengo V, Tripodi A, Reber G, Rand J, Ortel L, Galli M, et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009;7:1737-40.
17. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
18. Amengual O, Atsumi T, Khamashta MA, Koike T, Hughes GR. Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1996;35:1239-43.
19. Bertolaccini ML, Murru V, Sciascia S, Sanna G, Khmashta MA. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE). Thromb Res 2012;130:914-8.
20. Ortona E, Capozzi A, Colasanti T, Conti F, Alessandri C, Longo A, et al. Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. Blood 2010;116:2960-7.
21. Sciascia S, Murru, Sanna G, Roccatello D, Khamashta MA, Bertolaccini ML. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Hemost 2012;10:2512-8.
22. Chighizola CB, Raschi E, Banzato A, Orgghi MO, Pengo V, Meroni PL. The challenges of lupus anticoagulants. Expert Rev Hematol 2016;9:389-400.
23. Bertolaccini ML, Sciascia S, Murru V, Garcia-Fernandez C, Sanna G, Khamashta M. Antibodies to phosphatidylserine/prothrombin (aPS/PT) are an independent risk factor for thrombosis in patients with systemic lupus erythematosus (SLE). Arthritis Rheum 2011;63 Suppl 10:S9.
24. Pregnolato F, Chighizola CB, Encabo S, Shums Z, Norman GL, Tripodi A, et al. Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS? Immunol Res 2013;56:432-8.
25. Mullen MT, Messé SR, Kasner SE, Sansing L, Husain MR, Norman GL, et al. Anti-phosphatidylserine-prothrombin antibodies are associated with outcome in a TIA cohort. Front Neurol 2012;3:1-5.
26. Mahler M, Norman GL, Meroni PL, Khamashta MA. Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmun Rev 2012;12:313-7.
27. Mahler M, Albesa R, Zohoury N, Bertolaccini ML, Ateka-Barrutia O, Rodriguez-Garcia JL, et al. Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome. Lupus 2016;25:911-6.
28. Amengual O, Forastiero R, Sugiura-Ogasawara M, Otomo K, Oku K, Favas C, et al. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study. Lupus 2017;26:266-76.
29. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML. GAPSS: the Global Anti-Phospholipid Syndrome Score. Rheumatology 2013;52:1397-403.
30. Otomo K, Atsumi T, Amengual O, Fujieda Y, Kato M, Oku K, et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum 2012;64:504-12.
31. Mondejar R, González-Rodríguez C, Toyos-Sáenz de Miera FJ, Melguizo-Madrid E, Zohoury N, Mahler M, et al. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome. Clin Chim Acta 2014;431:174-8.
32. Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA. Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome. Ann Rheum Dis 2013;72:142-3.
33. Sciascia S, Cuadrado MJ, Sanna G, Murru S, Roccatello D, Khamashta MA, et al. Thrombotic risk assessment in systemic lupus erythematosus: validation of the Global Antiphospholipid Syndrome Score (GAPSS) in a prospective cohort. Arthritis Care Res 2014;66:1915-20.
34. Zuily S, de Laat B, Mohamed S, Kelchtermans H, Shums Z, Albesa R, et al. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study. Rheumatology 2015;54:2071-5.
35. De Jesus GR, Agmon-Levin N, Andrade CA, Andreoli L, Chighizola CB, Porter TF, et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev 2014;13:795-813.